Dec 2017

J.P. Morgan 36th Annual Healthcare Conference (January 8 – 11, 2018)

PolyPid's senior management will attend the J.P. Morgan 36th Annual Healthcare Conference, to be held on January 8 - 11, 2018 in San Francisco, California, USA.

Oct 2017

The Innovations in Cardiovascular Interventions – ICI Meeting (December 3-5, 2017)

PolyPid will participate at the ICI meeting with its product candidate D-PLEX in the ICI Meeting, to be held in David Intercontinental hotel, Tel Aviv, Israel. PolyPid’s presentation titled: “D-PLEX™: Novel Solution for Prevention of surgical Site Infections” will be presented by Dr. Noam Emanuel, PolyPid’s Chief Technology Officer on Monday December 4th at 14:00 -15:30 section in Hall 7.

Aug 2017

The 37th Annual Meeting of the Israel Orthopaedic Association (December 13-14, 2017)

PolyPid’s abstract “Enhanced bone healing of Gustilo III severe open tibia fractures treated by immediate antibiotic-formulated bone grafting” was accepted for Oral presentation at the 37th Annual Meeting of the Israel Orthopaedic Association, to be held in David Intercontinental, Tel Aviv, Israel, on December, 13-14 2017. Prof. Moshe Salai, Head Orthopedic Division, Tel Aviv Sourasky Medical Center, ISRAEL, will present in Hall B, on December 13th, at 9:00AM.

Jul 2017

The 7th Annual Partnership Opportunities in Drug Delivery (PODD) (October 19- 20, 2017)

Dr. Tamar Alon, PolyPid’s Chief Business Development Officer, will present at the Partnership Opportunities in Drug Delivery (PODD) meeting, to be held on October 19- 20, 2017 in Marriott Copley Place, Boston, MA, USA. Dr. Alon's presentation titled: “PLEX™ Local Drug Delivery Platform: Revolutionizing Medicine by Enabling Localized, Controlled and Prolonged Therapeutics” will take place in Track 1B on October 19th at 5:15 pm.

Aug 2017

The 36th EBJIS (European Bone and Joint Infection Society) Annual Meeting (September 7-9, 2017)

PolyPid’s abstract “Enhanced bone healing of Gustilo III severe open tibia fractures treated by immediate implantation of antibiotic-formulated bone grafting” was accepted to the 36th Annual Meeting of the European Bone and Joint Infection Society which will be held in Nantes, France, on 7-9 September 2017. The abstract will be presented in the poster presentation.

Jun 2017

The 2017 BIO International Convention in San Diego (June 19-22, 2017)

PolyPid will take part at the BIO International Convention, the world’s largest conference in the field of life sciences, showcasing the world's leading companies and developments in the fields of medical technology and life sciences. PolyPid will be represented by Mr. Amir Weisberg (CEO) as well as Dr. Tamar Alon (CBD) and Dr. Dan Popovic (CBO).

Apr 2017

American Association for Thoracic Surgery – AATS Centennial, 55th International conference (April 29- May 1, 2017, Boston, MA)

PolyPid will participate at the AATS conference with its product candidate D-PLEX. To learn more about our interim Phase Ib results as well as plans for starting up the Phase III clinical trial in the US, come and visit us at the Booth 831 in the exhibition hall.

Jun 2017

J.P. Morgan 35th Annual Healthcare Conference (January 9-12, 2017)

PolyPid's senior management will attend the J.P. Morgan 35th Annual Healthcare Conference, to be held on January 9-12, 2017 in San Francisco, California, USA.

Nov 2016

Oppenheimer Israel private companies conference (November 13th, 2016)

Dikla Czaczkes Akselbrad, PolyPid’s Chief Strategy Officer, will present PolyPid at the third annual, Oppenheimer Israel promising private companies conference, to be held on November 13th, at the David Intercontinental in Tel Aviv, Israel.

May 2016

ALTernatives to ANTibiotics (ALTANT) Conference (May 18-20, 2016)

PolyPid’s and BALI's (Biofilm Alliance) abstract was accepted to be presented at the Alternatives to Antibiotics (ALTANT) conference to be held on May 18-20, 2016 in Utrecht, The Netherlands. The abstract, titled: "Prevention of Staphylococcus aureus biomaterial-associated infections using a polymer-lipid coating containing LL-37-derived antimicrobial peptides", will be presented by Dr. Martijn Riool, Research Scientist, University of Amsterdam.

Technology

The PLEX™ (Polymer-Lipid Encapsulation matriX) platform is a matrix made of alternating layers of polymers and lipids that allows controlled, local release of unmodified drugs over extended periods of time.

Read More >

D-PLEX™

Provides safe and effective local antibiotic protection against SSI (surgical Site Infection) at the needed tissues or organs by administration during surgical procedures.

Read More >

BonyPid-1000™

Comprised of antibiotic eluting ß tri-calcium phosphate (ßTCP) granules, designed for bone related infections applications.

Read More >